A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Enable more effective and targeted treatments that address unique needs for patients with pharmacogenomics. The traditional one-size-fits-all approach to medication has long been recognized as a ...
21hon MSN
Black and low-income patients face disparities in access to genetic testing, Penn study finds
At Penn Medicine’s clinic where adults receive genetic counseling and testing, about 9% of patients are Black. By contrast, one in four patients at the cardiology and endocrinology clinics located in ...
In recent years, the U.S. Food and Drug Administration has approved more than a dozen gene-editing and cell-based therapies. We are now in the second great wave of the genetic revolution, not defined ...
This photo provided by Emilys Entourage in April 2025 shows Emily Kramer-Golinkoff, who has cystic fibrosis caused by a rare genetic mutation, during a trip to Maine. (Emilys Entourage via AP) ...
Research co-led by King's College London and Sidra Medicine, Qatar, has produced the most detailed map to date of large-scale ...
The critical work of those racing to cure rare pediatric diseases got an important shot in the arm today. Florida’s newly created Sunshine Genetics Consortium promises hope for children living with ...
State Sen. Danny Burgess and state Rep. Adam Anderson have filed legislation that would address a shortage of genetic ...
UKRI Innovate UK and NRC IRAP provide funding and advisory support, fostering UK-Canada collaboration in genetic medicine innovation. Chromatin Bioscience, Mediphage Bioceuticals, and Entos ...
Emily Kramer-Golinkoff can’t get enough oxygen with each breath. Advanced cystic fibrosis makes even simple things like walking or showering arduous and exhausting. She has the most common fatal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results